FastFunds Financial announced that Pure Grow Systems, LLC, a subsidiary of FastFunds Financial Corporation, inked a distribution agreement with Byoplanet to market its high-end electrostatic sprayers, giving Pure Grow the capability to treat any size facility. Regarded as the world’s most advanced chemical delivery system, the Byoplanet ES120 sprayer utilizes induction charged technology to produce electrically charged droplets that reach further and penetrate deeper, allowing 100% of the surface to be reached; including hidden areas and sensitive equipment.

“We are excited to be adding this state of the art product line to complement our antimicrobial sanitation system for grow facilities,” said Russ Mitchell, Pure Grow Systems managing partner. “The capability to reach 100% of the surfaces being treated including hidden areas and sensitive equipment will give our customers the ultimate value.”

With label approval in Nevada recently gained, Pure Grow plans to start an advertising campaign shortly. The company is expecting additional label approvals in the near future and the shareholders will be updated as these events occur.

For more information, visit www.fastfundsfinancial.com

Let us hear your thoughts: Fastfunds Financial Corp. Message Board

Fusion Telecommunications International is a leading provider of integrated cloud solutions to businesses of all sizes. The company’s advanced, proprietary cloud service platform enables the integration of cutting-edge solutions – including cloud voice and unified communications, cloud connectivity, cloud computing and additional cloud services such as storage and security – that promote enhanced security, flexibility, scalability and speed of deployment for its customers.

The company’s established standing in the cloud-related technology industry puts it in a favorable position to capitalize on the market’s forecast growth in the coming years. According to a report by IHS Technology, cloud-related tech spending is expected to triple from 2011 to 2017; amounting to a projected $235 billion by the end of the period.

In the first quarter of 2015, Fusion successfully leveraged this market performance to promote improved financial results, achieving a 10 percent year-over-year increase in consolidated sales. Likewise, the company took steps toward securing future financial growth by identifying approximately $2 billion in cost saving opportunities following the full integration of recent acquisitions.

“Our performance during the first quarter of 2015 reflects our ongoing efforts to position Fusion for sustained, long-term growth by investing in our infrastructure, products and personnel required to accelerate our growth strategy,” Matthew Rosen, chief executive officer of Fusion, stated in a news release. “We continue to believe that our expanding scale, robust nationwide network and end-to-end suite of innovative yet proven cloud solutions… are critical to Fusion’s success as we execute on our growing pipeline of opportunities.”

In recent weeks, Fusion has had tremendous success in expanding its market reach. Earlier this month, the company secured a deal with a major Housing Commission to provide its fully integrated suite of cloud solutions for a three year term. This contract, which is expected to provide Fusion with nearly $400,000 in revenue, could open the door for significant expansion in the future. The company built on this progress last week when it announced an expanded relationship with an industry-leading provider of employer-sponsored early education and child care programs to provide cost effective cloud connections designed to increase productivity. Through this partnership, Fusion is introducing its proven services to more than 400 locations across the country.

For prospective shareholders, the growth potential of the cloud-related technology market makes Fusion an extremely intriguing investment opportunity moving forward. Look for the company to utilize the additional market reach provided by its recent acquisitions in order to promote sustainable financial growth and favorable investor returns for the foreseeable future.

For more information, visit www.fusionconnect.com

Dominovas Energy, an energy-solutions company headquartered in Atlanta, GA, today reported that it has selected Pyrenees Investments, LLC to be its investment bank to prepare a private placement of shares of common stock and warrants to purchase shares of common stock for gross proceeds of up to US$10 million.

The Company plans to use the net proceeds of the offering, excluding any future proceeds from the exercise of the warrants, to fund working capital and other general corporate purposes. The offering is expected to close prior to the end of Q3 2015, subject to satisfaction of customary closing conditions. Pyrenees Investments is acting as the company’s placement agent on a best efforts basis.

The capital raised will allow Dominovas Energy to expand its energies in the manufacture and deployment of clean, reliable and sustainable power generation via the RUBICON™, its Solid Oxide Fuel Cell (SOFC) system. Eric Fresh, Sr. Vice President of Finance and Investments, commented, “Hiring Pyrenees Investments to secure investment capital to support the working capital needs of Dominovas Energy further enhances the Company’s ability to expand its efforts to meet the documented demand for increased power generation and electricity supply worldwide.

“Equally important, the capital raise, as proposed, would promote a financing structure that more appropriately supports the long-term growth prospects and objectives of Dominovas Energy. Given Dominovas Energy’s elevated trading profile, evidenced by daily volume and the increased presence of institutional investors, the Company is consistently attracting an ever more knowledgeable and supportive investor base that is affording us the opportunity to secure financing through structures that typically are more often utilized for funding growth stage, pre-revenue public companies.”

Mr. Fresh added, “As a company, we are quickly graduating from a typical micro-cap company’s reliance on the use of potentially toxic forms of convertible debt and equity-based financing. Conversely, financing structures involving common shares with warrants align the interests of investors more closely to those of the Company.”

For more information, visit the company’s website at www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

According to a report by Food Allergy Research & Education, an estimated 15 million Americans currently live with food allergies. Between 1997 and 2011, the prevalence of these allergies increased by approximately 50 percent, leading to an annual economic cost of nearly $25 billion in today’s market. Despite this growth, researchers are unsure of the cause of these sometimes debilitating reactions, creating a serious medical need for tools to deal with the potential health effects associated with these allergies. Content Checked Holdings, Inc. (OTCQB: CNCK) is addressing this market through the continued development and commercialization of ContentChecked®, a family of mobile apps for individuals with specific dietary requirements and preferences.

“Born from a father’s confusion and frustration about what to feed his daughter and her friends with specific food allergies, ContentChecked was founded to design and develop solutions that will positively impact individuals’ health,” Kris Finstand, chief executive officer of CNCK, stated in a news release. “Indeed, ContentChecked is both useful, but, also necessary due to insufficient labeling laws in the U.S. and ‘shifting’ manufacturing practices.”

ContentChecked is a groundbreaking tool for people with food allergies, as it allows for accurate classification of a wide variety of products through a simple barcode scan. Available on both Apple’s App Store and Google Play, the app uses an intuitive control scheme to allow users to register specific dietary requirements. Following this registration, CNCK’s app provides an immediate solution to finding out if a product fits a person’s dietary needs. If a product isn’t a safe option, ContentChecked provides a list of potential alternatives, making it ideal for families with newly diagnosed food allergies that are still learning how to find safe foods.

Moving forward, CNCK will look to leverage the scalability of its app suite in order to expand its market share in the growing food allergy industry. In June, the company took a significant step toward sustainable growth by uplisting to the OTCQB marketplace. In addition to ensuring a commitment to accountability and transparency for shareholders, this move is also a major milestone toward CNCK’s goal of uplisting to the NASDAQ stock market at a later date.

For prospective investors, CNCK’s rapidly expanding presence in the growing and underserved food allergy market could provide a platform for strong returns in the months to come.

For more information, visit www.contentchecked.com

According to a report by Food Allergy Research & Education, an estimated 15 million Americans currently live with food allergies. Between 1997 and 2011, the prevalence of these allergies increased by approximately 50 percent, leading to an annual economic cost of nearly $25 billion in today’s market. Despite this growth, researchers are unsure of the cause of these sometimes debilitating reactions, creating a serious medical need for tools to deal with the potential health effects associated with these allergies. Content Checked Holdings, Inc. (OTCQB: CNCK) is addressing this market through the continued development and commercialization of ContentChecked®, a family of mobile apps for individuals with specific dietary requirements and preferences.

“Born from a father’s confusion and frustration about what to feed his daughter and her friends with specific food allergies, ContentChecked was founded to design and develop solutions that will positively impact individuals’ health,” Kris Finstand, chief executive officer of CNCK, stated in a news release. “Indeed, ContentChecked is both useful, but, also necessary due to insufficient labeling laws in the U.S. and ‘shifting’ manufacturing practices.”

ContentChecked is a groundbreaking tool for people with food allergies, as it allows for accurate classification of a wide variety of products through a simple barcode scan. Available on both Apple’s App Store and Google Play, the app uses an intuitive control scheme to allow users to register specific dietary requirements. Following this registration, CNCK’s app provides an immediate solution to finding out if a product fits a person’s dietary needs. If a product isn’t a safe option, ContentChecked provides a list of potential alternatives, making it ideal for families with newly diagnosed food allergies that are still learning how to find safe foods.

Moving forward, CNCK will look to leverage the scalability of its app suite in order to expand its market share in the growing food allergy industry. In June, the company took a significant step toward sustainable growth by uplisting to the OTCQB marketplace. In addition to ensuring a commitment to accountability and transparency for shareholders, this move is also a major milestone toward CNCK’s goal of uplisting to the NASDAQ stock market at a later date.

For prospective investors, CNCK’s rapidly expanding presence in the growing and underserved food allergy market could provide a platform for strong returns in the months to come.

For more information, visit www.contentchecked.com

Natural Health Trends Corp., through its subsidiaries, is an international direct-selling and e-commerce company marketing premium quality personal care products throughout Asia, North America and Europe. The company’s revolutionary products – including anti-aging and hydrating cleansers, creams, lotions, serums and toners, as well as weight management, intimacy support and energy enhancing supplements – are sold under the trusted NHT Global brand, which is currently available in more than 40 countries. NHTC’s mission is to continue expanding upon its wellness tradition through a commitment to innovation and new health trends, providing a platform upon which to create sustainable value for both customers and shareholders moving forward.

In the first quarter of 2015, NHTC utilized this strategy to achieve considerable financial growth. According to its quarterly report, the company realized a 76 percent year-over-year increase in revenue for the period, with the majority of this growth coming in the competitive Hong Kong market. According to the company’s recently announced second quarter estimate, it has built upon its strong start to 2015 in recent months. NHTC estimated revenue for the second quarter to be $69.7 million, which, when verified, will represent a year-over-year increase of more than 100 percent.

“We have delivered a great start for the year,” Chris Sharng, president of NHTC, stated in a news release. “Our success in Greater China continues, attributable to the effectiveness of our leadership development, products, training and marketing programs.”

In addition to posting strong results in Asia, NHTC made considerable progress in North American personal care markets during the first half of the year. Through these efforts, the company could gain improved access to the consistently performing U.S. personal care industry, which, according to Statista, has recorded annual rises in sales for more than two decades, accounting for over $283 billion in 2013. Recent progress toward building brand recognition throughout North America could allow NHTC to increase its share of this expansive market in the future.

“We are also excited to see significant increases in North America, albeit from a small base,” continued Sharng. “Along with our initiatives in Southeast Asia, we may develop more sources for growth.”

The company’s recent financial performance makes it an intriguing investment opportunity in the months to come. Look for NHTC to continue building upon its established presence in the Asian personal care market, as well as expanding upon its recent progress in North America, in order to promote sustainable shareholder returns for the foreseeable future.

For more information, visit www.naturalhealthtrendscorp.com

Eco-Stim Energy Solutions, Inc. (NASDAQ: ESES) is an environmentally-focused oilfield services and technology company providing proprietary field management technologies and well stimulation and completion services to oil and gas producers in the international unconventional shale markets. Through a unique process designed to predict high probability production zones, the company offers its clients an opportunity to decrease the number of stages stimulated in shale plays, providing the means for dramatically reduced emissions, surface footprint and water usage. Led by a management team with well over a century of cumulative industry experience, Eco-Stim is currently looking to build upon the strong results of its first full quarter of operations.

In the first quarter of 2015, Eco-Stim initiated start-up field operations in Argentina, demonstrating the considerable progress made over the course of the previous three years. During the period, the company performed well stimulation jobs for three unique customers in four different provinces throughout the South American nation, achieving initial revenues of $2.9 million despite relatively low utilization figures. Moving forward, Eco-Stim expects these projects to serve as qualifiers for a collection of active operators in the region, providing a platform for dramatically increased revenue in the years to come.

“In January 2012, we formed this company with the specific goal of providing best-in-class oilfield services in undersupplied markets around the world,” J. Chris Boswell, president and chief executive officer of Eco-Stim, stated in a news release. “I am very proud of the outstanding team we have brought together in Argentina to make Eco-Stim a success. We have an excellent service record and one of the safest operations in the country.”

The company expects to increase its utilization capacity in the coming months by introducing a second well stimulation fleet to its current Argentina-based operations. Through this growth, Eco-Stim will be in a strengthened strategic position to capitalize on the forecast increases in drilling activity in the Vaca Muerta formation of Argentina’s Neuquén province, which is expected to rise despite slumping global oil prices. In April, prospective investors were given a preview of this potential production increase when a 45,000 barrel per day surge in shale output was ordered by the Argentine government in order to combat the country’s current energy deficit, according to Reuters.

In recent weeks, Eco-Stim has turned much of its focus toward securing the necessary capital to adequately expand its current operations. In June, the company announced a public offering of common stock shares that is expected to raise gross proceeds of up to $30 million. With these funds, Eco-Stim will secure its second pressure pumping fleet ahead of expanding its utilization capacity. For potential shareholders, the company’s rapidly growing position within one of the world’s most promising oil production regions makes it an intriguing investment opportunity.

For more information, visit www.ecostim-es.com

Scleroderma is a chronic connective tissue disease that affects an estimated 300,000 people within the United States, according to the National Women’s Health Information Center. The disease is commonly associated with excessive collagen that narrows blood vessels, restricting the flow of blood to body tissues and organs and severely limiting the movement of patients’ fingers and hands. Cytori Therapeutics, Inc. (NASDAQ: CYTX) is addressing this critically underserved medical need through the continued development of ECCS-50.

ECCS-50 utilizes Cytori’s proprietary Cell Therapy™ technology, which has been shown to improve blood flow, modulate the immune system and facilitate wound repair. As a same-day treatment option using a clinical-grade preparation of the patient’s own readily available cells, the company’s technology has demonstrated a significant therapeutic impact on both acute and chronic conditions, making its scleroderma indication particularly intriguing for prospective shareholders.

In the first quarter of 2015, Cytori took a major step in the development of ECCS-50 by gaining full approval for a pivotal phase III trial for the treatment of hand dysfunction associated with scleroderma. This clinical study, which is expected to initiate enrollment in the coming weeks, headlines an extremely promising development pipeline that currently features two late-stage U.S. trials, as well as two advanced programs in international markets.

The company’s actions in recent months have focused on securing the required capital to continue development of its drug candidates. In June, the company announced a restructured debt agreement that significantly reduced its interest rate while providing repayment deferral options that will allow Cytori to more efficiently pursue development milestones.

“The restructured loan considerably reduces our near-term financing cash obligations and… significantly strengthens our balance sheet,” Tiago Giaro, chief financial officer of Cytori, stated in a news release. “We are now laser-focused on the execution of our key clinical objectives with continued emphasis on our… U.S. pivotal phase III scleroderma clinical trials.”

Moving forward, Cytori will continue to progress with the development of its leading product candidates. Look for the company to advance enrollment of its highly-anticipated scleroderma trial in the weeks to come, clearing the way for the initiation of its phase III study in the near future.

For more information, visit www.cytori.com

The Singing Machine Company, the North American leader in consumer karaoke entertainment systems, is ushering in the next iteration of karaoke technology through the upcoming release of its new Digital Download line of products. Scheduled for launch this fall, the Digital Download lineup will introduce a host of new features designed to take the classic singing experience to the next level – including high-definition karaoke videos, a downloadable library featuring more than 10,000 songs, a preloaded flash drive to store songs and recordings, and an intuitive custom playlist creator.

Upon release, SMDM’s innovative new product line will be available nationwide through the company’s industry-leading distribution partners, such as Toys ‘R’ Us, Sam’s Club and Costco. By integrating support for Bluetooth™ audio streaming and the Singing Machine Mobile Karaoke App, which is available on iOS, SMDM will look to expand its market share in the consistently performing entertainment market.

“[W]e are continuing to evolve our products to incorporate the latest technology to improve the karaoke experience and promote access to music through karaoke downloads and streaming,” Gary Atkinson, chief executive officer of SMDM, stated in a news release. “We believe this will increase our product’s appeal to a wider consumer demographic and create new revenue streams to the company.”

In recent years, the company has utilized this strategy to great success, recording consistent financial growth. During its fiscal year ending March 2015, SMDM’s karaoke systems were stocked in more than 10,000 storefronts throughout North America, leading to more than one million sold units. In total, the company realized a 25 percent year-over-year increase in net sales for the period on the way to its fourth consecutive fiscal year of profitability.

SMDM has leveraged the timeless popularity of the consumer karaoke market to promote favorable returns for well over three decades. As one of the first companies to provide these systems for home entertainment in the United States, SMDM has built a collection of recognizable, trusted brands within the niche market – including The Singing Machine®, SoundX®, Home™ and SMDigital™.

For more information, visit www.singingmachine.com

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medications. Utilizing its proprietary BioErodible MucoAdhesive (BEMA®) drug delivery technology, the company is developing new applications of proven therapies aimed at addressing important unmet medical needs. By building upon previously approved therapeutics, BDSI is able to adhere to a more time-efficient regulatory pathway, effectively shortening the development process and providing a streamlined method for the company to pursue its ultimate goal of enhancing patient care.

The company’s product portfolio includes two unique treatment options currently approved for commercialization – ONSOLIS®, for the treatment of breakthrough cancer pain, and BUNAVAIL™, for the treatment of opioid dependence. In the first quarter of 2015, BDSI made significant progress with both of these products. In particular, BUNAVAIL recorded a 25 percent month-over-month growth average in prescription sales throughout the period, and the company reacquired North American marketing rights for ONSOLIS, clearing the way for future commercialization.

“We continue to make progress with the launch of BUNAVAIL,” Dr. Mark A. Sirgo, president and chief executive officer of BDSI, stated in a news release. “[W]e are making significant advancements in securing managed care and pharmacy access to BUNAVAIL… providing additional access to over 30,000 prescriptions each month.”

Through the ongoing launch of BUNAVAIL, BDSI gains access to a large and significantly underserved market within the U.S. pharmaceutical industry. According to the U.S. Department of Health and Human Services, approximately 2.5 million people throughout the country are currently dependent on prescription opioids. As a result, the current market for the treatment of opioid dependence was estimated at $1.7 billion in 2013, demonstrating the considerable market potential of BUNAVAIL.

In May, BDSI took a major step toward capitalizing on this potential through the expansion of its sales and managed markets teams. Through these hires, the company added valuable sales and managed markets experience that’s expected to drive substantial growth in both sales and market share in the months to come.

“We are extremely pleased to have hired a number of key sales and managed markets personnel previously with Salix, a leader in its respective field and one driven by a strong commercial sales organization,” continued Sirgo. “This provides us with a strong sales and managed markets leadership team as we continue to advance the commercialization of BUNAVAIL.”

For prospective shareholders, BDSI’s favorable product pipeline should provide a platform for sustainable market growth in the future. Look for the company to leverage this positioning in order to promote strong returns moving forward.

For more information, visit www.bdsi.com